ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CTU Chad Therapeutics,

0.00
0.00 (0.00%)
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Chad Therapeutics, AMEX:CTU AMEX Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Directorate Change

27/03/2003 5:17pm

UK Regulatory


RNS Number:3138J
Conister Trust PLC
27 March 2003

                               Conister Trust PLC

                             Re Directorate Change

The board of Conister Trust is pleased to announce the appointment of Gareth
Alan Jones, BSc, ACIB, MBA as an Executive Director with effect from 31 March
2003.

Mr Jones, aged 34, has had a career which has spanned 13 years in retail and
corporate banking, both in the UK and overseas. As well as traditional banking
experience with National Westminster Bank, he has held roles in investor
relations and e-commerce, and has specialised in project management. Former
positions include a senior consultancy role with iXL and with Standard Chartered
Bank. He is an Associate of the Institute of Financial Services, a graduate in
chemistry and holds an MBA from London Business School. He is Manx resident.

There are no other matters which are required to be announced as required under
paragraph (f) of Schedule 2 of the AIM Rules.

27 March 2003


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
BOABRGDXXBDGGXR

1 Year Chad Therapeutics Chart

1 Year Chad Therapeutics Chart

1 Month Chad Therapeutics Chart

1 Month Chad Therapeutics Chart